Restart Life Sciences Corp. (CSE: HEAL) is a publicly traded Canadian company focused on building a portfolio of functional wellness and health-focused consumer brands.

Manufacturing Infrastructure

Holy Crap complete manufacturing facility in Gibsons, British Columbia, provides control over production, quality, and future product innovation.

Established Consumer Brand

Restart Life owns 100% of Holy Crap Foods, a recognized functional cereal brand currently distributed across 800+ retail locations in Canada.

Retail Distribution Network

Holy Crap products are represented across major retail banners including Metro, Whole Foods, Save-On-Foods, Safeway, London Drugs, Healthy Planet, IGA, Longo's, and more.

Strategic Expansion Opportunities

Management continues to evaluate additional acquisitions, partnerships, and brand opportunities that complement the Company’s growing wellness portfolio.

Investment Highlights

Restart Life Sciences is building a scalable wellness platform positioned to capitalize on growing global demand for functional foods and health-focused consumer products. 

Science-Based Product Development

Strategic collaboration with the University of Manitoba’s Richardson Centre for Food Technology and Research supports evidence-based functional product development.

Why Consider Restart Life (CSE: HEAL)

  • Restart Life offers investors exposure to multiple growth drivers within the expanding health, wellness, and functional food sectors.

  • Consumers are increasingly prioritizing nutrition, cognitive health, and preventative wellness, creating significant demand for functional food products.

  • Holy Crap™ provides an existing revenue base and retail presence that can be expanded through marketing, product innovation, and broader distribution.

  • Ownership of manufacturing capabilities enables greater control over production, margins, and new product development.

  • The Company’s research collaboration with the University of Manitoba strengthens its ability to develop innovative, evidence-informed wellness products.

  • Restart Life is building an operational framework capable of supporting multiple brands across retail, digital, and international markets.

Market Opportunity

The global health and wellness market continues to experience strong long-term growth as consumers prioritize nutrition, preventative health, and functional foods.

• Rising consumer interest in functional foods

• Increased focus on cognitive health and mental performance

• Growing demand for plant-based, clean-label nutrition

• Expansion of direct-to-consumer wellness brands

• Greater awareness of the gut-brain connection and digestive health

Functional foods represent one of the fastest-growing segments of the broader wellness industry, with increasing consumer demand for products that deliver both nutrition and measurable health benefits.

Restart Life is positioning its portfolio to participate in these trends through functional cereals, cognitive nutrition products, and science-backed wellness solutions.

Corporate Overview

Restart Life Sciences Corp. is focused on building a diversified platform of health and wellness consumer brands that address the evolving needs of modern, health-conscious consumers.

The Company approaches growth through a combination of

• Strategic brand acquisitions

• Product innovation in functional foods and wellness

• Science-backed product development

• Scalable manufacturing and distribution infrastructure

• Expansion across retail and direct-to-consumer channels


By combining consumer brands, research collaborations, and operational assets, Restart Life is building a vertically integrated ecosystem designed to support sustainable growth and brand development.

CSE-Listed: Restart Life Sciences
(Ticker: HEAL)

  • Share Outstanding: 59,252,354
    Reserved for Issuance: 13,137,000

    (As of Feb 25, 2026)

  • CSE | OTC | FSE

  • From startups to seasoned brands, we partner with people who care about doing things right—and doing them well.

  • Olympia Trust Company

  • Kreston GTA LLP

  • Lawson Lundell LLP 

Investor Relations